Test for Alzheimer’s disease directly measures synaptic loss
Researchers have tested a new method for directly measuring synaptic loss in individuals with Alzheimer’s disease. The method, which uses PET imaging technology to scan
Researchers have tested a new method for directly measuring synaptic loss in individuals with Alzheimer’s disease. The method, which uses PET imaging technology to scan
One major problem with understanding Alzheimer’s is not being able to clearly see why the disease starts. A super-resolution ‘nanoscope’ now provides a 3D view
Authors lament the unmet promise of a miracle drug for Alzheimer disease but are heartened by what they see as encouraging improvements in care (care
Researchers document the health problems that precede a diagnosis of multiple sclerosis.